Dual targeting of vascular endothelial growth factor (VEGF) with sorafenib and bevacizumab: Clinical and translational results

被引：0
|
作者：
Azad, N. S. [1 ]
Annunziata, C. [1 ]
Barrett, T. [1 ]
Chen, C. [1 ]
Steinberg, S. [1 ]
Kwitkowski, V. E. [1 ]
McNally, D. [1 ]
Kotz, H. [1 ]
Minasian, L. [1 ]
Kohn, E. C. [1 ]
机构：
[1] NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3542
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review
    Eskens, Ferry A. L. M.
    Verweij, Jaap
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (18) : 3127 - 3139
  • [2] Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: Preclinical and clinical aspects
    Abdel-Rahman, Omar
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 93 (01) : 18 - 27
  • [3] TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN RHEUMATOID ARHTRITIS (RA)
    Tomos, C.
    Imprialos, K.
    Siskos, N.
    Tsartsalis, S.
    Mironidou-Tzouveleki, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 198 - 198
  • [4] The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFR) polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib
    Faloppi, Luca
    Scartozzi, Mario
    Loretelli, Cristian
    Bianconi, Maristella
    Giampieri, Riccardo
    Bittoni, Alessandro
    Del Prete, Michela
    Mandolesi, Alessandra
    Bearzi, Italo
    Cascinu, Stefano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] THE ROLE OF TUMOUR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS (VEGFR) POLYMORPHISMS IN THE PREDICTION OF CLINICAL OUTCOME FOR ADVANCED HEPATOCELLULAR CARCINOMA RECEIVING SORAFENIB
    Faloppi, L.
    Scartozzi, M.
    Baroni, G. Svegliati
    Loretelli, C.
    De Minicis, S.
    Mandolesi, A.
    Bianconi, M.
    Bearzi, I.
    Benedetti, A.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 243 - 243
  • [6] The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFR) polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib
    Faloppi, Luca
    Scartozzi, Mario
    De Minicis, Samulele
    Baroni, Gianluca Svegliati
    Bianconi, Maristella
    Giampieri, Riccardo
    Maccaroni, Elena
    Bittoni, Alessandro
    Del Prete, Michela
    Mandolesi, Alessandra
    Loretelli, Cristian
    Belvederesi, Laura
    Biagetti, Simona
    Bearzi, Italo
    Benedetti, Antonio
    Cascinu, Stefano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Nicholas Papadopoulos
    Joel Martin
    Qin Ruan
    Ashique Rafique
    Michael P. Rosconi
    Ergang Shi
    Erica A. Pyles
    George D. Yancopoulos
    Neil Stahl
    Stanley J. Wiegand
    [J]. Angiogenesis, 2012, 15 : 171 - 185
  • [8] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Papadopoulos, Nicholas
    Martin, Joel
    Ruan, Qin
    Rafique, Ashique
    Rosconi, Michael P.
    Shi, Ergang
    Pyles, Erica A.
    Yancopoulos, George D.
    Stahl, Neil
    Wiegand, Stanley J.
    [J]. ANGIOGENESIS, 2012, 15 (02) : 171 - 185
  • [9] Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
    Ranieri, Girolamo
    Patruno, Rosa
    Ruggieri, Eustachio
    Montemurro, Severino
    Valerio, Paolo
    Ribatti, Domenico
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (16) : 1845 - 1857
  • [10] Analysis of the binding affinity of vascular endothelial growth factor A (VEGF) to ranibizumab, aflibercept and bevacizumab
    Wang, Xiangdan
    Yang, Jihong
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345